Current issue
Archive
About the Journal
About us
Aims and Scope
Indexing and Abstracting
Editorial Office
Open Access Policy
Publication Ethics
Contact
For Authors
Editorial Policy
Peer Review Policy
Manuscript Preparation Guidelines
Copyright & Licensing
Publication Fees
Fast-Track Paper Publication Option
Conflict Interest Guidance
Submit an Article
Special Issues
News & Editorials
“Fake,” “Predatory,” and “Pseudo” Journals: Charlatans Threatening Trust in Science
Shifting the Journal submission-review system to the Editorial System Manuscript December 27, 2017.
ORIGINAL ARTICLE
One-year follow-up of patients screened for lower extremity arterial disease
1
Department of Vascular and Endovascular Surgery, Heart and Vascular Center, Semmelweis University, Budapest, HUNGARY
2
Institute of Behavioural Sciences, Semmelweis University, Budapest, HUNGARY
3
Heim Pál Children’s Hospital, Budapest, HUNGARY
4
South-Buda Center Hospital - St. Imre University Teaching Hospital, Budapest, HUNGARY
Publication date: 2022-07-26
Electron J Gen Med 2022;19(6):em399
KEYWORDS
ABSTRACT
Background:
We tested a screening algorithm of lower extremity arterial disease (LEAD) for general practitioners (GPs) with a 1-year follow-up examination. Besides, patients were referred for vascular specialists to verify the presence of LEAD with specific tools.
Method:
327 patients were followed-up. We recorded the differences in the anamnesis. Ankle brachial index was re-measured. Patients repeated walking-test. We compared our results to the specialist control.
Results:
Specialists confirmed LEAD in 73.7%. 63.1% reported IC symptoms. Our screening algorithm had a sensitivity of 92%, and a specificity of 96%, positive and negative predictive values were 91% and 96%. Most LEAD-positive patients received LEAD-specific medications (94.2%) and antiplatelet therapy (91.7%). Improvement in walking test were shown in 96 cases (29.3%).
Conclusion:
Our screening algorithm combined with specialist control has proven to be an easy-to-apply, and efficient methodology for GPs with excellent sensitivity and specificity in identifying individuals at risk of LEAD.
We tested a screening algorithm of lower extremity arterial disease (LEAD) for general practitioners (GPs) with a 1-year follow-up examination. Besides, patients were referred for vascular specialists to verify the presence of LEAD with specific tools.
Method:
327 patients were followed-up. We recorded the differences in the anamnesis. Ankle brachial index was re-measured. Patients repeated walking-test. We compared our results to the specialist control.
Results:
Specialists confirmed LEAD in 73.7%. 63.1% reported IC symptoms. Our screening algorithm had a sensitivity of 92%, and a specificity of 96%, positive and negative predictive values were 91% and 96%. Most LEAD-positive patients received LEAD-specific medications (94.2%) and antiplatelet therapy (91.7%). Improvement in walking test were shown in 96 cases (29.3%).
Conclusion:
Our screening algorithm combined with specialist control has proven to be an easy-to-apply, and efficient methodology for GPs with excellent sensitivity and specificity in identifying individuals at risk of LEAD.
REFERENCES (59)
1.
Tendera M, Aboyans V, Bartelink ML, et al. ESC guidelines on the diagnosis and treatment of peripheral artery diseases: Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries: The task force on the diagnosis and treatment of peripheral artery diseases of the European Society of Cardiology (ESC). Eur Heart J. 2011;32(22):2851-906. https://doi.org/10.1093/eurhea... PMid:21873417.
2.
Criqui MH, Denenberg JO, Langer RD, Fronek A. The epidemiology of peripheral arterial disease: importance of identifying the population at risk. Vasc Med. 1997;2(3):221-6. https://doi.org/10.1177/135886... PMid:9546971.
3.
Criqui MH. Peripheral arterial disease--epidemiological aspects. Vasc Med. 2001;6(3 Suppl):3-7. https://doi.org/10.1177/135883... PMid:11789963.
4.
Schroll M, Munck O. Estimation of peripheral arteriosclerotic disease by ankle blood pressure measurements in a population study of 60-year-old men and women. J Chronic Dis. 1981;34(6):261-9. https://doi.org/10.1016/0021-9....
5.
Hiatt WR, Marshall JA, Baxter J, et al. Diagnostic methods for peripheral arterial disease in the San Luis valley diabetes study. J Clin Epidemiol. 1990;43(6):597-606. https://doi.org/10.1016/0895-4....
6.
Selvin E, Erlinger TP. Prevalence of and risk factors for peripheral arterial disease in the United States: Results from the national health and nutrition examination survey, 1999-2000. Circulation. 2004;110(6):738-43. https://doi.org/10.1161/01.CIR... PMid:15262830.
7.
Sansone R, Busch L, Langhoff R. [Update ESC-guideline 2017: Focus on PAD]. Dtsch Med Wochenschr. 2018;143(20):1455-9. https://doi.org/10.1055/a-0588... PMid:30286494.
8.
Hiatt WR, Hoag S, Hamman RF. Effect of diagnostic criteria on the prevalence of peripheral arterial disease. The San Luis valley diabetes study. Circulation. 1995;91(5):1472-9. https://doi.org/10.1161/01.CIR... PMid:7867189.
9.
Gerhard-Herman MD, Gornik HL, Barrett C, et al. 2016 AHA/ACC guideline on the management of patients with lower extremity peripheral artery disease: Executive summary: A report of the American College of Cardiology/American Heart Association Task Force on clinical practice guidelines. Circulation. 2017;135(12):e686-e725. https://doi.org/10.1161/CIR.00....
10.
Hooi JD, Stoffers HE, Kester AD, et al. Risk factors and cardiovascular diseases associated with asymptomatic peripheral arterial occlusive disease. The Limburg PAOD study. Peripheral arterial occlusive disease. Scand J Prim Health Care. 1998;16(3):177-82. https://doi.org/10.1080/028134... PMid:9800232.
11.
Bainton D, Sweetnam P, Baker I, Elwood P. Peripheral vascular disease: Consequence for survival and association with risk factors in the speedwell prospective heart disease study. Br Heart J. 1994;72(2):128-32. https://doi.org/10.1136/hrt.72... PMid:7917683 PMCid:PMC1025474.
12.
Diehm C, Schuster A, Allenberg JR, et al. High prevalence of peripheral arterial disease and co-morbidity in 6880 primary care patients: Cross-sectional study. Atherosclerosis. 2004;172(1):95-105. https://doi.org/10.1016/S0021-....
13.
Kolossváry E, Ferenci T, Kováts T, et al. Trends in major lower limb amputation related to peripheral arterial disease in Hungary: A nationwide study (2004-2012). Eur J Vasc Endovasc Surg. 2015;50(1):78-85. https://doi.org/10.1016/j.ejvs... PMid:25842279.
14.
Dózsa C, Szeberin Z, Sótonyi P, et al. [The territorial distribution of amputations in healthcare and social context in Hungary in 2016-2017]. Orv Hetil. 2020;161(18):747-55. https://doi.org/10.1556/650.20... PMid:32338478.
15.
Yap Kannan R, Dattani N, Sayers RD, Bown MJ. Survey of ankle-brachial pressure index use and its perceived barriers by general practitioners in the UK. Postgrad Med J. 2016;92(1088):322-7. https://doi.org/10.1136/postgr... PMid:26846131.
16.
Bridgwood BM, Nickinson AT, Houghton JS, Pepper CJ, Sayers RD. Knowledge of peripheral artery disease: What do the public, healthcare practitioners, and trainees know? Vasc Med. 2020;25(3):263-73. https://doi.org/10.1177/135886... PMid:32000617.
17.
Davies JH, Kenkre J, Williams EM. Current utility of the ankle-brachial index (ABI) in general practice: Implications for its use in cardiovascular disease screening. BMC Fam Pract. 2014;15:69. https://doi.org/10.1186/1471-2... PMid:24742018 PMCid:PMC4021160.
18.
Tóth-Vajna Z, Tóth-Vajna G, Gombos Z, Szilágyi B, Járai Z, Sótonyi P. [A summary of data of screening of the lower limb peripheral arterial diseases in the region of Northern Hungary]. Orv Hetil. 2020;161(33):1382-90. https://doi.org/10.1556/650.20... PMid:32749233.
19.
Diehm C, Lange S, Darius H, et al. Association of low ankle brachial index with high mortality in primary care. Eur Heart J. 2006;27(14):1743-9. https://doi.org/10.1093/eurhea... PMid:16782720.
20.
Chen Q, Li L, Chen Q, et al. Critical appraisal of international guidelines for the screening and treatment of asymptomatic peripheral artery disease: A systematic review. BMC Cardiovasc Disord. 2019;19(1):17. https://doi.org/10.1186/s12872... PMid:30646843 PMCid:PMC6332557.
21.
Bavry AA, Anderson RD, Gong Y, et al. Outcomes among hypertensive patients with concomitant peripheral and coronary artery disease: findings from the INternational VErapamil-SR/Trandolapril STudy. Hypertension. 2010;55(1):48-53. https://doi.org/10.1161/HYPERT... PMid:19996066 PMCid:PMC3000120.
22.
Boylan L, Nesbitt C, Wilson L, et al. Reliability of the Edinburgh claudication questionnaire for identifying symptomatic PAD in general practice. Angiology. 2021;72(5):474-9. https://doi.org/10.1177/000331... PMid:33401955.
23.
Haigh KJ, Bingley J, Golledge J, Walker PJ. Barriers to screening and diagnosis of peripheral artery disease by general practitioners. Vasc Med. 2013;18(6):325-30. https://doi.org/10.1177/135886... PMid:24105616.
24.
Hirsch AT, Criqui MH, Treat-Jacobson D, et al. Peripheral arterial disease detection, awareness, and treatment in primary care. JAMA. 2001;286(11):1317-24. https://doi.org/10.1001/jama.2... PMid:11560536.
25.
Tóth-Vajna Z, Tóth-Vajna G, Gombos Z, et al. Screening of peripheral arterial disease in primary health care. Vasc Health Risk Manag. 2019;15:355-63. https://doi.org/10.2147/VHRM.S... PMid:31686829 PMCid:PMC6709362.
26.
Farkas K, Kolossváry E, Járai Z. Simple assessment of quality of life and lower limb functional capacity during cilostazol treatment - results of the SHort-tERm cIlostazol eFFicacy and quality of life (SHERIFF) study. Vasa. 2020;49(3):235-42. https://doi.org/10.1024/0301-1... PMid:31983287.
27.
Farkas K, Járai Z, Kolossváry E, Ludányi A, Clement DL, Kiss I. High prevalence of peripheral arterial disease in hypertensive patients: The evaluation of ankle-brachial index in Hungarian hypertensives screening program. J Hypertens. 2012;30(8):1526-32. https://doi.org/10.1097/HJH.0b... PMid:22743684.
28.
Benjamin EJ, Blaha MJ, Chiuve SE, et al. Heart disease and stroke statistics-2017 update: A report from the American Heart Association. Circulation. 2017;135(10):e146-e603. https://doi.org/10.1161/CIR.00....
29.
Criqui MH, Vargas V, Denenberg JO, et al. Ethnicity and peripheral arterial disease: The San Diego population study. Circulation. 2005;112(17):2703-7. https://doi.org/10.1161/CIRCUL... PMid:16246968.
30.
Fowkes FG, Rudan D, Rudan I, et al. Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: A systematic review and analysis. Lancet. 2013;382(9901):1329-40. https://doi.org/10.1016/S0140-....
31.
Hirsch AT, Duval S. The global pandemic of peripheral artery disease. Lancet. 2013;382(9901):1312-4. https://doi.org/10.1016/S0140-....
32.
Song P, Rudan D, Zhu Y, et al. Global, regional, and national prevalence and risk factors for peripheral artery disease in 2015: An updated systematic review and analysis. Lancet Glob Health. 2019;7(8):e1020-e30. https://doi.org/10.1016/S2214-....
33.
Patel T, Baydoun H, Patel NK, et al. Peripheral arterial disease in women: The gender effect. Cardiovasc Revasc Med. 2020;21(3):404-8. https://doi.org/10.1016/j.carr... PMid:31327711.
34.
Aboyans V, Criqui MH, Abraham P, et al. Measurement and interpretation of the ankle-brachial index: A scientific statement from the American Heart Association. Circulation. 2012;126(24):2890-909. https://doi.org/10.1161/CIR.0b... PMid:23159553.
35.
Schorr EN, Treat-Jacobson D, Lindquist R. The relationship between peripheral artery disease symptomatology and ischemia. Nurs Res. 2017;66(5):378-87. https://doi.org/10.1097/NNR.00... PMid:28858146 PMCid:PMC5661996.
36.
Singh GD, Armstrong EJ, Waldo SW, et al. Non-compressible ABIs are associated with an increased risk of major amputation and major adverse cardiovascular events in patients with critical limb ischemia. Vasc Med. 2017;22(3):210-7. https://doi.org/10.1177/135886... PMid:28466753.
37.
Lilly SM, Qasim AN, Mulvey CK, Churchill TW, Reilly MP, Eraso LH. Non-compressible arterial disease and the risk of coronary calcification in type-2 diabetes. Atherosclerosis. 2013;230(1):17-22. https://doi.org/10.1016/j.athe... PMid:23958247.
38.
Williams B, Mancia G, Spiering W, et al. 2018 ESC/ESH guidelines for the management of arterial hypertension: The task force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension: The task force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension. J Hypertens. 2018;36(10):1953-2041. https://doi.org/10.1097/HJH.00... PMid:30234752.
39.
Fowkes FG, Housley E, Riemersma RA, et al. Smoking, lipids, glucose intolerance, and blood pressure as risk factors for peripheral atherosclerosis compared with ischemic heart disease in the Edinburgh Artery Study. Am J Epidemiol. 1992;135(4):331-40. https://doi.org/10.1093/oxford... PMid:1550087.
40.
Chen D, Wu LT. Smoking cessation interventions for adults aged 50 or older: A systematic review and meta-analysis. Drug Alcohol Depend. 2015;154:14-24. https://doi.org/10.1016/j.drug... PMid:26094185 PMCid:PMC4536122.
41.
Hobbs SD, Bradbury AW. Smoking cessation strategies in patients with peripheral arterial disease: An evidence-based approach. Eur J Vasc Endovasc Surg. 2003;26(4):341-7. https://doi.org/10.1016/S1078-....
42.
Kumar R, Prasad R. Smoking cessation: An update. Indian J Chest Dis Allied Sci. 2014;56(3):161-9. https://doi.org/10.5005/ijcdas....
43.
Lancaster T, Stead LF. Individual behavioural counselling for smoking cessation. Cochrane Database Syst Rev. 2017;3(3):Cd001292. https://doi.org/10.1002/146518... PMid:28361496 PMCid:PMC6464359.
44.
Sampson UK, Fowkes FG, McDermott MM, et al. Global and regional burden of death and disability from peripheral artery disease: 21 world regions, 1990 to 2010. Glob Heart. 2014;9(1):145-58.e21. https://doi.org/10.1016/j.ghea... PMid:25432124.
45.
Song P, Rudan D, Wang M, Chang X, Rudan I. National and subnational estimation of the prevalence of peripheral artery disease (PAD) in China: A systematic review and meta-analysis. J Glob Health. 2019;9(1):010601. https://doi.org/10.7189/jogh.0... PMid:30873278 PMCid:PMC6377796.
46.
Baubeta Fridh E, Andersson M, Thuresson M, et al. Amputation rates, mortality, and pre-operative comorbidities in patients revascularised for intermittent claudication or critical limb ischaemia: A population based study. Eur J Vasc Endovasc Surg. 2017;54(4):480-6. https://doi.org/10.1016/j.ejvs... PMid:28797662.
47.
Firnhaber JM, Powell CS. Lower extremity peripheral artery disease: Diagnosis and treatment. Am Fam Physician. 2019;99(6):362-9.
48.
Fok PW, Lanzer P. Media sclerosis drives and localizes atherosclerosis in peripheral arteries. PLoS One. 2018;13(10):e0205599. https://doi.org/10.1371/journa... PMid:30365531 PMCid:PMC6203409.
49.
Wild SH, Byrne CD, Smith FB, Lee AJ, Fowkes FG. Low ankle-brachial pressure index predicts increased risk of cardiovascular disease independent of the metabolic syndrome and conventional cardiovascular risk factors in the Edinburgh artery study. Diabetes Care. 2006;29(3):637-42. https://doi.org/10.2337/diacar... PMid:16505519.
50.
Elnady BM, Saeed A. Peripheral vascular disease: The beneficial effect of exercise in peripheral vascular diseases based on clinical trials. Adv Exp Med Biol. 2017;1000:173-83. https://doi.org/10.1007/978-98... PMid:29098622.
51.
Gardner AW, Addison O, Katzel LI, et al. Association between physical activity and mortality in patients with claudication. Med Sci Sports Exerc. 2021;53(4):732-9. https://doi.org/10.1249/MSS.00... PMid:32991346 PMCid:PMC7969371.
52.
Lane R, Harwood A, Watson L, Leng GC. Exercise for intermittent claudication. Cochrane Database Syst Rev. 2017;12(12):Cd000990. https://doi.org/10.1002/146518... PMid:29278423.
53.
Marcial JM, Pérez R, Vargas P, Franqui-Rivera H. Non-invasive therapy of peripheral arterial disease. Bol Asoc Med P R. 2015;107(3):52-7.
54.
Vemulapalli S, Dolor RJ, Hasselblad V, et al. Comparative effectiveness of medical therapy, supervised exercise, and revascularization for patients with intermittent claudication: A network meta-analysis. Clin Cardiol. 2015;38(6):378-86. https://doi.org/10.1002/clc.22... PMid:25963038 PMCid:PMC6711096.
55.
Gerage AM, Correia MA, Oliveira PML, et al. Physical activity levels in peripheral artery disease patients. Arq Bras Cardiol. 2019;113(3):410-6. https://doi.org/10.5935/abc.20... PMid:31365605 PMCid:PMC6882394.
56.
Brown T, Forster RB, Cleanthis M, Mikhailidis DP, Stansby G, Stewart M. Cilostazol for intermittent claudication. Cochrane Database Syst Rev. 2021;6:Cd003748. https://doi.org/10.1002/146518... PMid:34192807 PMCid:PMC8245159.
57.
Cimminiello C, Arpaia G, Polo Friz H, et al. A prospective multicentre study on the treatment of cardiovascular risk factors and claudication symptoms in patients with peripheral artery disease (the IDOMENEO study). Vasa. 2015;44(5):371-9. https://doi.org/10.1024/0301-1... PMid:26317257.
58.
De Donato G, Setacci F, Galzerano G, Mele A, Ruzz U, Setacci C. The use of cilostazol in patients with peripheral arterial disease: results of a national physician survey. J Cardiovasc Surg (Torino). 2016.
59.
Shiga T, Sahara H, Orito K. Combination of cilostazol and L-carnitine improves walking performance in peripheral arterial disease model rats. Pharmacology. 2015;96(5-6):210-6. https://doi.org/10.1159/000439... PMid:26329263.
Share
RELATED ARTICLE
| eISSN: | 2516-3507 |
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
